奧密克戎加強(qiáng)針：英國(guó)率先批準(zhǔn)莫德納二價(jià)疫苗

Moderna’s two-strain shot will target both the original Covid-19 strain and BA.1 in step with European regulators
該疫苗針對(duì)新冠病毒原始毒株和Omicron BA.1亞型毒株。此舉為英國(guó)使用這款疫苗開(kāi)展秋季加強(qiáng)劑接種工作奠定基礎(chǔ)。 The Medicines and Healthcare products Regulatory Authority — which was the first in the world to approve an original Covid-19 jab — has granted a conditional authorisation to the vaccine, which targets both the original strain of the virus and Omicron BA.1. 
該疫苗針對(duì)新冠病毒原始毒株和Omicron BA.1亞型毒株。英國(guó)藥品和保健品監(jiān)管局(MHRA)——全球首個(gè)批準(zhǔn)原始新冠疫苗的監(jiān)管機(jī)構(gòu)——已給予這款疫苗有條件授權(quán)。  
The vaccine is authorised for use in people aged 18 or over but the UK plans to focus its booster programme to prepare for rising cases over the winter on the over 50s and those at higher clinical risk of developing severe Covid-19.
該疫苗獲準(zhǔn)用于18歲或以上的人群，但英國(guó)的加強(qiáng)劑接種計(jì)劃擬聚焦于50歲以上人群以及有較高臨床風(fēng)險(xiǎn)罹患新冠重癥的人群，以求針對(duì)冬季病例增加的前景做好準(zhǔn)備。